English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 13 July 2020, 06:00 HKT/SGT
Share:
        

Source: Lifequest World Corp / Biopipe Global
Lifequest (LQWC) subsidiary Biopipe Global enters US Wastewater Market
Ships its Revolutionary 100% Sludge-Free Biological Sewage Treatment Plant to California

Ridgefield Park, NJ, July 13, 2020 - (ACN Newswire) - Lifequest (LQWC) subsidiary Biopipe Global, with its revolutionary sludge and chemical-free sewage treatment technology, has shipped one plant to the United States from Turkey, in spite of the Covid-19 disruptions which have shut down procurement from the company's primary manufacturer in India. With a capacity of 10 cubic meters per day (2,640 gallons per day), the plant will be installed at a campground in Southern California.




Enes Kutluca, the CEO of Biopipe, said, "This is also the first fully assembled and ready to install plant we have shipped from Turkey. We have implemented a new process with our manufacturer, PIMTAS, which will allow us to ship ready-to-install systems with capacity ranging from 2 to 15 cubic meters per day. We recognize that the California Water Board (CWB) is one of the toughest water regulators in the world, but we are confident to meet their effluent discharge standards."

Max Khan, the President & CEO of Lifequest, said, "We did not intend to enter the US market until 2021, due to the regulatory hurdles and certifications required, and our focus on Asia and Africa. But with strong interest from several states, we decided to start with the toughest: California faces an intractable water crisis and recycling wastewater is the only way out. Our Biopipe system is an effective solution for onsite wastewater treatment, as it produces non-potable water that can be reused. California represents an enormous opportunity for Biopipe."

About Lifequest & Biopipe

Lifequest offers both effluent treatment (ETP) and sewage treatment (STP) solutions. Biopipe, a wholly owned subsidiary, has developed a patented 100% sludge-free, chemical-free, odor-free, silent, easy to assemble and install, scalable, low cost, ecological and virtually maintenance-free onsite sewage wastewater treatment system which treats both grey and black water. Treated water exceeds EU and all local standards for discharge and can be reused for irrigation, flushing and cleaning.

Biopipe is protected by patent rights internationally and since its introduction, it has been very well received and widely acknowledged. Years of R&D has led to the development of one of the most sustainable, eco-friendly, efficient and cost effective onsite wastewater treatment solutions in the world. Biopipe offers a unique value proposition for consumers, companies and governments seeking sustainable water management solutions.

Contact http://www.biopipe.co, Tanmay Pawale, [email protected] or Nina Aquino, [email protected].

Or visit http://www.lifequestcorp.com (OTC:LQWC), e: [email protected], or call: +1-646-201-5242.

Topic: Press release summary
Sectors: Water, Agritech, Environment, HealthCare, Const/Eng, Hospitality
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Jacobson Pharma Submits Form A1 to Spin-off Its Branded Healthcare Business  
Sept 23, 2020 20:30 HKT/SGT
ADERA and BreadTalk Group to Establish Technology JV to Develop Innovative Fintech and Digital Solutions for SMEs  
Sept 23, 2020 18:00 HKT/SGT
Fashion talent shines at CENTRESTAGE  
Sept 23, 2020 17:00 HKT/SGT
Mitsubishi Corporation: Use of CO2 in Concrete / Partnership with Blue Planet Systems Corporation  
Sept 23, 2020 15:00 HKT/SGT
Hitachi Hosts "Hitachi Social Innovation Forum 2020 TOKYO ONLINE"  
Sept 23, 2020 13:22 HKT/SGT
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay  
Sept 23, 2020 12:00 HKT/SGT
Hitachi ABB Power Grids Launches Open and Scalable Ecosystem for Digitalization of Transformers  
Sept 23, 2020 09:38 HKT/SGT
Fujitsu to Deliver New Supercomputer System for Canon  
Sept 23, 2020 09:25 HKT/SGT
Eisai Receives Positive Opinion from EMA's CHMP on Use of Antiepileptic Agent Fycompa in Pediatric Patients  
Sept 23, 2020 08:24 HKT/SGT
Eisai and Merck Present First-Time Data From Two Studies Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020  
Sept 23, 2020 08:10 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575